Table 2.
Outcomes for 90-day follow up
| Outcomes | All patients(n = 118) | ESI (cm2/m2) | P value | |
|---|---|---|---|---|
| <12.05 (n = 58) | ≥ 12.05 (n = 60) | |||
| Mortality, n (%) | 46(39.0) | 30(51.7) | 16(26.7) | 0.005 |
| Development of kidney dysfunction, n (%)a | 33(32.4) | 20(43.5) | 13(23.2) | 0.029 |
| Development of hepatic encephalopathy, n (%)b | 27(25.7) | 19(39.6) | 8(14.0) | 0.003 |
| Development of in-hospital infection, n (%)c | 53(68.8) | 27(75.0) | 26(63.4) | 0.273 |
Abbreviations. ESI: erector spine index. a: Except for 16 patients with kidney dysfunction at baseline including 12 in the group with ESI<12.05 cm2/m2 and 4 in the group with ESI ≥ 12.05 cm2/m2; b: Except for 13 patients with hepatic encephalopathy at baseline including 10 in group with ESI<12.05 cm2/m2 and 3 in group with ESI ≥ 12.05 cm2/m2; c: Except for 41 patients with in-hospital infection at baseline including 22 in group with ESI<12.05 cm2/m2 and 19 in group with ESI ≥ 12.05 cm2/m2